Public Health Emergency - Leading a Nation Prepared
ASPR, in partnership with the Johns Hopkins University Applied Physics Laboratory, has developed the COVID-19 Monoclonal Antibody Therapeutics Calculator for Infusion Sites (mAbs Calculator). The mAbs Calculator is a free, data-informed decision support tool that is based on a comprehensive simulation framework. The mAbs Calculator can be used to inform staffing decisions and resource investments needed for COVID-19 monoclonal antibody therapeutic infusion sites.The mAbs Calculator was developed using advanced simulation and modeling tools in real-time to inform the implementation of mAb treatments. More than 162,000 alternative scenarios that take into account staffing and capacity levels, scheduling protocols, patient demand, facility service hours, and infusion durations were considered in the development of this tool.
COVID-19 mAb therapeutics can help reduce the strain on hospital systems by decreasing the need for hospitalization of high-risk COVID-19 patients with mild to moderate symptoms, and FDA recommends IV administration of these treatments. A wide range of clinical settings have implemented mAb infusion sites, including large heath care systems, emergency departments, medical sites, rural health providers, ambulatory care facilities, long-term care facilities, urgent care sites, and federally qualified health sites. The mAbs Calculator can help hospitals and health care facilities:
The mAbs Calculator is flexible and easy to use – it has just eight questions. Information on your site’s capacity, staffing, and procedures are input using a series of standardized drop-down menus.Nurses and clinical support staff are primary drivers of the capacity of an infusion site. Other roles and activities, such as physicians, pharmacists, registration, testing, and referral may be needed to implement an infusion site, but are not listed as inputs for this tool.
The mAbs Calculator provides valuable information to decision makers about ways that physical capacity and staffing inputs affect critical performance metrics such as:
Using this information about how infusion beds and nurses translate into treated patients and other performance metrics, existing mAb infusion sites can tailor their capacity and staffing levels. New mAb infusion sites can use this information to effectively plan and move forward with implementation efforts.
Check out the new ASPR COVID-19 Therapeutics Site
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language | Vulnerability Disclosure Policy
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages